PCV40 COST-EFFECTIVENESS OF EVOLOCUMAB IN ATHEROSCLEROTIC CARDIOVASCULAR DISEASE PATIENTS WITH VARYING RISK PROFILES IN SWEDEN
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.765
https://www.valueinhealthjournal.com/article/S1098-3015(19)33143-2/fulltext
Title :
PCV40 COST-EFFECTIVENESS OF EVOLOCUMAB IN ATHEROSCLEROTIC CARDIOVASCULAR DISEASE PATIENTS WITH VARYING RISK PROFILES IN SWEDEN
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)33143-2&doi=10.1016/j.jval.2019.09.765
First page :
Section Title :
Open access? :
No
Section Order :
10669